Paul Kolodzik, MD - Semaglutide/Ozempic, Everything Blood Glucose

Dr. Paul Kolodzik, MD, is a double board-certified emergency and metabolic-health physician with thirty years of experience. As a private-practice, MetabolicMD, Dr. Kolodzik has used continuous glucose monitoring (CGM) to help thousands of patients lose weight and prevent and reverse disease. In his first book, The Continuous Glucose Monitoring Revolution, Dr. Kolodzik presents a comprehensive program for metabolic health success using CGM. He has been using the GLP-1 medications since they were first approved by the FDA in 2017. He was one of the early physician prescribers of these medications to help his patients achieve weight loss and improved metabolic health. In his metabolic health and weight loss practice, Dr. Kolodzik has assisted over 1,000 patients lose weight and reverse chronic diseases such as prediabetes, diabetes, hypertension, high cholesterol, fatty liver disease, and sleep apnea. https://www.amazon.com/Continuous-Glucose-Monitor-Revolution-Monitoring-ebook/dp/B0C4MP8MJN   https://www.metabolicmds.com/   Thanks to Neurohacker and their incredible anti-aging formula with Qualia Senolytic for sponsoring the show to improve physical and mental energy as we age! Go to neurohacker.com/SCOTT for up to 50% off Qualia Senolytic and as a listener of The Scott Mys Show use code SCOTT at checkout for an extra 15% off your first purchase. It's backed by a 100-day money-back guarantee so try for yourself risk-free today.   LMNT is offering a free sample pack along with any regular purchase when you use my custom link drinklmnt.com/carnivorecast . The LMNT Sample Pack includes 1 packet of every flavor. This is the perfect offer for 1) anyone who is interested in trying all of our flavors or 2) wants to introduce a friend to LMNT. Go to drinklmnt.com/carnivorecast to claim this awesome deal!   What questions would you like answered or who would you like to hear from in the carnivore or research community?   Let me know on Twitter, Instagram, and Facebook.